Exploring the acceptability of controlled human infection with SARSCoV2—a public consultation

Rapid development of an effective vaccine for SARSCoV2 is a global priority. A controlled human infection model (CHIM) would accelerate the efficacy assessment of candidate vaccines. This strategy would require deliberate exposure of volunteers to SARSCoV2 with no currently available treatment and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gbesemete, D., Barker, M., Lawrence, W. T., Watson, D., de Graaf, H., Read, R. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339437/
https://www.ncbi.nlm.nih.gov/pubmed/32635912
http://dx.doi.org/10.1186/s12916-020-01670-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339437/
https://www.ncbi.nlm.nih.gov/pubmed/32635912
http://dx.doi.org/10.1186/s12916-020-01670-2

Ejemplares similares